4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0000899243-16-020907
Director sold 13,253 shares at an average $10.09 ($133,735)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Canaan IX L.P. Director | 2016-05-23 | Sale | −12,053 | $10.10 | $121,735 | 4,564,015 | I |
| Canaan IX L.P. Director | 2016-05-24 | Sale | −1,200 | $10.00 | $12,000 | 4,562,815 | I |
| Open-market sales · 13,253 sh · avg $10.09 · $133,735 | |||||||
Loading xslF345X03/doc4.xml…